Get startedLog in
    Picture of Aurinia Pharmaceuticals logo

    AUPH — Aurinia Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    All News

    Aurinia to stop R&D on immunotherapies to focus on kidney disease drug

    Picture of Aurinia Pharmaceuticals logoAurinia Pharmaceuticals
    15/02/2024 11:07
    Feb 15 (Reuters) - Aurinia Pharmaceuticals  AUPH.O  will
stop research and development on its immunotherapies to focus on
its kidney disease drug Lupkynis, the company said on Thursday.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak
Dasgupta)
 ((Sriparna.Roy@thomsonreuters.com))

    Recent news on Aurinia Pharmaceuticals

    See all news